Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Trial of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects

NCT06062680 is registered in ClinicalTrials.gov with Jiangsu HengRui Medicine Co., Ltd. as lead sponsor.

NCT NCT06062680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06062680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Trial of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects
Lead sponsor
Jiangsu HengRui Medicine Co., Ltd.
Phase
Phase 1
Overall status
Unknown status
Start date
October 31, 2023
Completion date
November 15, 2023
Enrollment
15 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adult patients with chronic primary itp, adult patients with saa who do not respond well to immunosuppressive therapy